Cargando…
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
It is estimated that the prevalence rate of Alzheimer’s disease (AD) will double by the year 2040. Although currently available treatments help with symptom management, they do not prevent, delay the progression of, or cure the disease. Interestingly, a shared characteristic of AD and other neurodeg...
Autores principales: | Collins, Andrila E., Saleh, Tarek M., Kalisch, Bettina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868221/ https://www.ncbi.nlm.nih.gov/pubmed/35204096 http://dx.doi.org/10.3390/antiox11020213 |
Ejemplares similares
-
VANL-100 Attenuates Beta-Amyloid-Induced Toxicity in SH-SY5Y Cells
por: Collins, Andrila E., et al.
Publicado: (2022) -
Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
por: Nguyen, V. Phu, et al.
Publicado: (2023) -
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
por: Nelson, Mackayla L., et al.
Publicado: (2023) -
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018) -
Antioxidant Therapies for Alzheimer's Disease
por: Feng, Ye, et al.
Publicado: (2012)